Hella Danø

896 total citations
12 papers, 545 citations indexed

About

Hella Danø is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hella Danø has authored 12 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hella Danø's work include Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Hella Danø is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Hella Danø collaborates with scholars based in Denmark, United States and Norway. Hella Danø's co-authors include Anders N. Pedersen, Martin Berg, Jens Overgaard, S.J. Zimmermann, Birgitte Vrou Offersen, Marie Overgaard, Lise Bech Jellesmark Thorsen, Ingelise Jensen, Elsebeth Lynge and Marianne Ewertz and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and International Journal of Epidemiology.

In The Last Decade

Hella Danø

12 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hella Danø Denmark	7	310	251	143	118	108	12	545
Marie Larochelle Canada	12	283 0.9×	311 1.2×	101 0.7×	156 1.3×	167 1.5×	16	727
Mohamed A. Alm El‐Din Egypt	16	231 0.7×	243 1.0×	233 1.6×	207 1.8×	93 0.9×	37	586
Şefik İğdem Türkiye	16	148 0.5×	178 0.7×	193 1.3×	140 1.2×	148 1.4×	36	608
Bethany Anderson United States	16	242 0.8×	196 0.8×	174 1.2×	97 0.8×	189 1.8×	48	738
P. Poortmans Netherlands	11	170 0.5×	232 0.9×	127 0.9×	153 1.3×	168 1.6×	25	538
Pamela J. Schlembach United States	13	174 0.6×	179 0.7×	127 0.9×	221 1.9×	198 1.8×	31	562
R Collins Hong Kong	3	497 1.6×	256 1.0×	169 1.2×	220 1.9×	111 1.0×	3	682
Allan O. Langlands Australia	13	284 0.9×	247 1.0×	163 1.1×	160 1.4×	182 1.7×	33	592
A. Rodger United Kingdom	14	159 0.5×	230 0.9×	180 1.3×	130 1.1×	143 1.3×	21	596
Adrian Harnett United Kingdom	7	497 1.6×	273 1.1×	165 1.2×	228 1.9×	65 0.6×	9	615

Countries citing papers authored by Hella Danø

Since Specialization

Citations

This map shows the geographic impact of Hella Danø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hella Danø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hella Danø more than expected).

Fields of papers citing papers by Hella Danø

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hella Danø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hella Danø. The network helps show where Hella Danø may publish in the future.

Co-authorship network of co-authors of Hella Danø

This figure shows the co-authorship network connecting the top 25 collaborators of Hella Danø. A scholar is included among the top collaborators of Hella Danø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hella Danø. Hella Danø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bojesen, Stig E., Julia S. Johansen, Bent Ejlertsen, et al.. (2024). Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 33(5). 662–670. 1 indexed citations

Jensen, Maj‐Britt, Eva Balslev, Ann Knoop, et al.. (2024). Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial. Journal of Clinical Oncology. 43(4). 373–380. 3 indexed citations

Brems-Eskildsen, Anne Sofie, Søren Linnet, Hella Danø, et al.. (2020). Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer. Acta Oncologica. 60(2). 157–164. 9 indexed citations

Christensen, Ib Jarle, Eva Balslev, Ann Knoop, et al.. (2019). Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay. Breast Cancer. 27(2). 266–276. 1 indexed citations

Langkjer, Sven Tyge, Jeanette Dupont Jensen, Mie Grunnet, et al.. (2019). The NAME Trial: A Direct Comparison of Classical Oral Navelbine Versus Metronomic Navelbine in Metastatic Breast Cancer. Future Oncology. 15(22). 2561–2569. 6 indexed citations

Ejlertsen, Bent, Malgorzata Tuxen, Erik Jakobsen, et al.. (2017). Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for EarlyTOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial. Journal of Clinical Oncology. 35(23). 2639–2646. 47 indexed citations

Thorsen, Lise Bech Jellesmark, Birgitte Vrou Offersen, Hella Danø, et al.. (2015). DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. Journal of Clinical Oncology. 34(4). 314–320. 298 indexed citations

Thorup, Christian, Lars Sebbesen, Hella Danø, et al.. (2009). Carcinoma of the nasal cavity and paranasal sinuses in Denmark 1995–2004. Acta Oncologica. 49(3). 389–394. 63 indexed citations

Danø, Hella, Kasper D. Hansen, P. F. Jensen, et al.. (2004). Fertility pattern does not explain social gradient in breast cancer in denmark. International Journal of Cancer. 111(3). 451–456. 38 indexed citations

10.

Danø, Hella, et al.. (2004). Use of census data for construction of fertility history for Danish women. Scandinavian Journal of Public Health. 32(6). 435–441. 2 indexed citations

11.

Danø, Hella, Otto Andersen, Marianne Ewertz, Jørgen Holm Petersen, & Elsebeth Lynge. (2003). Socioeconomic status and breast cancer in Denmark. International Journal of Epidemiology. 32(2). 218–224. 66 indexed citations

12.

Danø, Hella, Thomas Skov, & Elsebeth Lynge. (1996). Underreporting of occupational cancers in Denmark. Scandinavian Journal of Work Environment & Health. 22(1). 55–57. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact